期刊文献+

川芎嗪与阿米洛利联用对肝星状细胞增殖及分泌细胞外基质的影响

Effects of Chuanxiongzine and Amiloride on Proliferation and Extracellular Matrix Secretion of Rat Hepatic Stellate Cells in vitro
在线阅读 下载PDF
导出
摘要 目的探讨钠氢交换抑制剂阿米洛利(Amiloride)与抗氧化剂川芎嗪联用对大鼠肝星状细胞(hepatic stellate cells,HSC)增殖及分泌细胞外基质的影响。方法用不同浓度的阿米洛利和川芎嗪处理大鼠肝星状细胞;以MTT比色法测定细胞的增殖;放射免疫法测定透明质酸和层黏连蛋白;酶联免疫吸附法(ELISA)测定Ⅰ型胶原水平。结果阿米洛利和川芎嗪均可剂量依赖性地抑制HSC增殖,不同程度抑制Ⅰ型胶原、透明质酸和层黏连蛋白分泌,联用组优于单用组。结论作用于HSC不同靶点的抗纤维化药物联用优于单用。 Objective To investigate the effects of antioxidant Chuanxiongzine and Na^+/H^+ exchanger inhibitor Amiloride on proliferation and extracellular matrix secretion of rat hepatic stellate cells in vitro. Methods HSC-T6 were incubated with different concentrations of Chuanxiongzine and Amiloride for 24 h. MTT colorimetry was used for assaying proliferation of HSC. Cytotoxicity was measured by LDH colorimetry. Type I collage was determined by ELISA. Hyaluronic Acid and Laminin were measured by Radioimmunoassay. Results 1-20 mol/L Chuanxiongzine and Amiloride added in culture medium had no cytotoxicity to HSC, but could significantly inhibite HSC proliferation, and also inhibite the secretion of Type I collage. Combining Chuanxiongzine with amiloride had better effects on proliferation and extracellular matrix secretion of rat hepatic stellate cells than single Chuanxiongzine or amiloride alone. Conclusion The effects of combination of antifibrosis drugs on different targets of HSC are superior to those of each one.
作者 张莉 左和宁
出处 《今日药学》 CAS 2008年第4期72-74,共3页 Pharmacy Today
关键词 川芎嗪 阿米洛利 肝星状细胞 Chuanxiongzine amiloride hepatic stellate cells
  • 相关文献

参考文献5

  • 1[1]Novo E,Marra F,Zarrmm E,et al.Dose dependent and divergent effects of superoxide anion on cell death,proliferation,and migration of activated human hepatic stellate cells.Gut,2006,55:90-97.
  • 2马金霞,潘世扬,张卫,童明庆.MTT比色法用于肿瘤细胞体外药物敏感性试验的检测[J].临床检验杂志,2002,20(2):104-104. 被引量:35
  • 3李友元,何福清,彭孝立,杨锡兰,罗玲,韩丽文.川芎嗪对CCl_4肝损伤的保护作用[J].湖南医科大学学报,1995,20(6):579-581. 被引量:8
  • 4[4]Quinn DA,Du HK,Thompson BT,cluinic pulmonary hypertension J.Am J Respir Crit Care Med,1998,157(4 Pt 1):1263-1268.
  • 5[5]Shah V.Cellar and molecular basis of portal hypertension J.Lin Liver Dis,2001,5:629-644.

二级参考文献6

共引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部